INTRODUCTION
An estimated 250,000 women were diagnosed with breast cancer in 2017 with over one-third undergoing a mastectomy as part of treatment, with mastectomy rates continuing to increase 1, 2 . Breast reconstruction rates postmastectomy have also increased from 12% in 1998 to upwards of 42% in 2016 and are continuing to rise 1 .
Currently, information addressing recovery after implant or flap-based reconstruction is limited to subjective, patient-reported outcomes. Objective data assessing critical functions of daily living such as sleep and resumption of baseline physical activities is lacking 3 . The current literature describes the patient's perspective on long-term recovery and surgical invasiveness of individual reconstructive procedures, ignoring the importance of shortterm recovery in surgical decision-making 3 .
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value that can also be assessed with patient-worn actigraphy devices. Secondly, we evaluated the performance of actigraphy devices to measure quantitative short-term post-operative data after mastectomy and reconstruction that can be used to inform patient decision-making.
METHODS

Patient-Defined Recovery Outcomes of Interest
This study was approved by a full institutional board review. Patients who had undergone mastectomy alone, mastectomy and implant-based reconstruction or mastectomy and autologous reconstruction less than one year previously were identified through our institution's survivorship program and invited to participate in one of three focus groups of 6 patients each to identify outcomes of relevance for surgical decision-making. With a standardized script and audiorecording, focus group facilitators asked patients to discuss their operative choice, post-operative experience, what they would have wanted to know, and the hardest aspects of their post-operative recovery to determine if the variables measured by the actigraphy device would be considered valuable to patients during surgical decision-making.
Perioperative Actigraphy
Women undergoing immediate free flap or pre-pectoral tissue expander placement after early stage breast cancer (Stage 0-II), who would not require axillary dissection, who owned a smartphone, had WiFi, and were willing to wear a smartwatch were eligible for inclusion. Recruitment occurred during a reconstructive consultation 2-3 weeks after receiving their breast cancer diagnosis. The Sensus application (SensusMobile UVA Apps LLC, Charlottesville, VA) and the Microsoft Band 2 (Microsoft Corporation, Redmond, WA) smartwatch were used to measure patient recovery at 1Hz measurement frequency combined with hourly and daily step and sleep measures from the Microsoft Health application.
Each patient wore an actigraphy device for a two-week baseline period followed by a three-month post-operative period to assess short-term recovery normalized to the patient's individual pre-operative data. Patient diaries were kept to help interpret the daily activities reflected by the actigraphy devices.
RESULTS
Focus Groups
Focus group discussions identified sleep quality, return of normal bowel function, ability to shower, drain removal, narcotic dependence, and return to work, driving and exercise as important early post-operative variables that were important to patient recovery in all three focus groups. Focus group administrators subjectively noted a majority of patients who had mastectomy alone prioritized drain removal and return to driving and exercise. A majority of patients having had implant based surgery prioritized sleep quality while those having had flap based surgery emphasized sleep quality and return to prior exercise and work. Sleep quality and return to regular activity could be measured by the sleep and step counts of an actigraphy device.
Actigraphy Results
Actigraphy devices were worn by four women undergoing immediate implant-based breast reconstruction and four women undergoing immediate flap reconstruction ( Table 1 describes their medical and demographic data).
Steps taken decreased immediately post-operatively and then slowly improved over time to approach the patients' baseline state for both expander-based and flap-based reconstruction (Figures 1-2) . By post-operative day 30, all patient's average steps were back within their baseline range. Variance in total and restful sleep initially increased after surgery, relative to baseline state, and then returned to baseline by post-operative day 20 ( Figure 3 ). Heart rate variability decreased immediately following surgery and then gradually returned to baseline around post-operative day 35 (Figure 4) . Patient compliance and device usability yielded post-operative data ranging from 2 weeks to 3 months of usable data per patient.
DISCUSSION
Through this pilot study, we were able to identify sleep quality, and return to activity as patient-selected variables important to surgical decision-making that can be captured quantitatively with actigraphy devices. Actigraphy data demonstrated a measurable decline in activity and heart rate variability as well as an increase in sleep variability after breast reconstruction that returned to patientnormalized baseline over a short-term recovery period.
Currently, reconstructive surgery consultations tend to focus on perioperative surgical risks, long term aesthetics, and revision rates with reportable data limited to subjective questionnaires 4 . By combining objective actigraphy data from women after reconstruction with subjective survey data, clinicians may provide a comprehensive picture of post-operative recovery focusing on outcome variables valued by patients [5] [6] [7] . Fortunately, an interest in studying real-time patient data parallels patient interest in wearable devices used to measure function for their personal convenience. While different devices vary in performance, validity across devices has been reported for steps traveled, activity levels, and sleep, the main outcome variables of our investigation 8 .
Patient-generated data and actigraphy devices have well-documented uses in other medical specialties 9, 10 . However, the application of this technology to surgical patients, in general, is limited and in post-mastectomy breast reconstruction, specifically, has not been described. Our report demonstrates that sleep patterns and activity can be measured after breast reconstruction without distracting variability to mask the overall trend. Wearable technology appears to be a promising adjunct to traditional post-operative patient reported outcomes measures. The resultant objective data can be analyzed and compared with validated patient reported outcomes, allowing for predictive modeling and aiding in future patient decision-making. Post-operative steps taken after implant based reconstruction with bilateral pre-pectoral tissue expanders. significant variability in steps taken after overnight stay in the hospital that correlated with self-reported pain ratings. By Pod 12, over half of her days exhibited activity above pre-operative baseline level.
The use of patient-worn actigraphy devices opens up an avenue for remote patient-monitoring to aid expeditious detection and treatment of surgical complications to help reduce health costs and detriment to the patient. We used remote, real-time monitoring to encourage compliance as the study progressed, similar to how patient care teams could monitor vital sign trends.
Further studies in a larger cohort of patients are indicated to compare outcomes of different types of reconstruction and draw further conclusions regarding average time to return of baseline activities, sleep, and other important quality of life measures as identified by patients. The current study makes the critical contribution of demonstrating the feasibility and utility of a system that Heart variability decreases as exhibited by shorter box plots and narrower trend lines of heart rate range for first 4 days after surgery with patient documenting narcotic use for 7 days. Heart rate variability increases as calculated activity index increases (data not shown) over Pod 5-13, and again Pod 14-55.
